Related Experiment Video

Updated: Jul 16, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Global risk management in patients with type 2 diabetes mellitus

Michael H Davidson1

  • 1Rush University Medical Center, Chicago, Illinois 60612, USA. michaeldavidson@radiantresearch.com

The American Journal of Cardiology
|February 20, 2007
PubMed

Insights

Aggressively managing risk factors like high cholesterol, glucose, and blood pressure is crucial for improving cardiovascular disease (CVD) outcomes in patients with type 2 diabetes mellitus. This comprehensive approach significantly reduces the absolute risk of cardiovascular events in this high-risk group.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Patients with type 2 diabetes mellitus (T2DM) face significantly elevated risks for cardiovascular disease (CVD).
  • The frequent co-occurrence of T2DM and hypertension necessitates intensive management strategies.
  • Effective risk factor modification is proven to enhance cardiovascular outcomes.

Purpose of the Study:

  • To emphasize the importance of aggressive risk factor management in T2DM patients.
  • To highlight the combined benefits of managing diabetes, hypertension, and cholesterol.
  • To outline strategies for reducing absolute cardiovascular risk in high-risk populations.

Main Methods:

  • Review of established guidelines for diabetes, hypertension, and dyslipidemia management.
  • Analysis of the impact of aggressive risk factor reduction on CVD outcomes.
  • Focus on achieving target levels for low-density lipoprotein (LDL), glucose, and blood pressure.

Main Results:

  • Aggressive modification of cardiovascular risk factors leads to improved CVD outcomes.
  • Intensified management of T2DM, hypertension, and LDL cholesterol is essential for this population.
  • Normalization of glucose and blood pressure, alongside LDL reduction, significantly lowers absolute cardiovascular risk.

Conclusions:

  • Comprehensive and aggressive risk factor management is vital for patients with T2DM.
  • Achieving therapeutic targets for diabetes, hypertension, and LDL cholesterol can substantially mitigate CVD risk.
  • Integrated management strategies are key to improving cardiovascular health in high-risk individuals with T2DM.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...